158 related articles for article (PubMed ID: 8219205)
1. Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood.
Wada M; Bartram CR; Nakamura H; Hachiya M; Chen DL; Borenstein J; Miller CW; Ludwig L; Hansen-Hagge TE; Ludwig WD
Blood; 1993 Nov; 82(10):3163-9. PubMed ID: 8219205
[TBL] [Abstract][Full Text] [Related]
2. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
[TBL] [Abstract][Full Text] [Related]
3. Mutations of p53 in Wilms' tumors.
Takeuchi S; Bartram CR; Ludwig R; Royer-Pokora B; Schneider S; Imamura J; Koeffler HP
Mod Pathol; 1995 Jun; 8(5):483-7. PubMed ID: 7675765
[TBL] [Abstract][Full Text] [Related]
4. [Molecular study on minute alterations of the p53 and the N-ras genes in hematologic malignancies].
Kurosawa M
Hokkaido Igaku Zasshi; 1994 May; 69(3):543-54. PubMed ID: 7927179
[TBL] [Abstract][Full Text] [Related]
5. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
Kawamura M; Ohnishi H; Guo SX; Sheng XM; Minegishi M; Hanada R; Horibe K; Hongo T; Kaneko Y; Bessho F; Yanagisawa M; Sekiya T; Hayashi Y
Leuk Res; 1999 Feb; 23(2):115-26. PubMed ID: 10071127
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia.
Kawamura M; Kikuchi A; Kobayashi S; Hanada R; Yamamoto K; Horibe K; Shikano T; Ueda K; Hayashi K; Sekiya T
Blood; 1995 May; 85(9):2546-52. PubMed ID: 7727782
[TBL] [Abstract][Full Text] [Related]
7. [Value of protein 53 expression in lymphoma. Its correlation with genetic mutations].
Echezarreta G; Marcos B; Sanz C; Martínez B; Benítez J; Oliva H; Rivas C
Sangre (Barc); 1997 Oct; 42(5):369-75. PubMed ID: 9424736
[TBL] [Abstract][Full Text] [Related]
8. [p53 and hematologic malignancies].
Preudhomme C; Fenaux P
Pathol Biol (Paris); 1997 Dec; 45(10):898-908. PubMed ID: 9769955
[TBL] [Abstract][Full Text] [Related]
9. The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing.
Ahuja HG; Foti A; Bar-Eli M; Cline MJ
Blood; 1990 Apr; 75(8):1684-90. PubMed ID: 2183888
[TBL] [Abstract][Full Text] [Related]
10. A unique spectrum of p53 mutations in B-cell chronic lymphocytic leukemia distinct from that of other lymphoid malignancies.
Newcomb EW; el Rouby S; Thomas A
Mol Carcinog; 1995 Dec; 14(4):227-32. PubMed ID: 8519411
[TBL] [Abstract][Full Text] [Related]
11. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies.
Ogawa S; Hangaishi A; Miyawaki S; Hirosawa S; Miura Y; Takeyama K; Kamada N; Ohtake S; Uike N; Shimazaki C
Blood; 1995 Aug; 86(4):1548-56. PubMed ID: 7632963
[TBL] [Abstract][Full Text] [Related]
12. Exon 5 mutations in the p53 gene in relapsed childhood acute lymphoblastic leukemia.
Blau O; Avigad S; Stark B; Kodman Y; Luria D; Cohen IJ; Zaizov R
Leuk Res; 1997 Aug; 21(8):721-9. PubMed ID: 9379679
[TBL] [Abstract][Full Text] [Related]
13. p53 abnormalities in B-cell prolymphocytic leukemia.
Lens D; De Schouwer PJ; Hamoudi RA; Abdul-Rauf M; Farahat N; Matutes E; Crook T; Dyer MJ; Catovsky D
Blood; 1997 Mar; 89(6):2015-23. PubMed ID: 9058723
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
[TBL] [Abstract][Full Text] [Related]
15. p53 gene analysis in childhood B non-Hodgkin's lymphoma.
Klumb CE; de Resende LM; Tajara EH; Bertelli EC; Rumjanek VM; Maia RC
Sao Paulo Med J; 2001 Nov; 119(6):212-5. PubMed ID: 11723536
[TBL] [Abstract][Full Text] [Related]
16. DNA sequence profile of TP53 gene mutations in childhood B-cell non-Hodgkin's lymphomas: prognostic implications.
Klumb CE; Furtado DR; de Resende LM; Carriço MK; Coelho AM; de Meis E; Maia RC; Rumjanek FD
Eur J Haematol; 2003 Aug; 71(2):81-90. PubMed ID: 12890146
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases.
Preudhomme C; Dervite I; Wattel E; Vanrumbeke M; Flactif M; Lai JL; Hecquet B; Coppin MC; Nelken B; Gosselin B
J Clin Oncol; 1995 Apr; 13(4):812-20. PubMed ID: 7707106
[TBL] [Abstract][Full Text] [Related]
18. Studies of the p53 gene mutation in Saudi non-Hodgkin's lymphoma.
Ahmad MF; Nasrin N; Akhtar M; Hannan MA
Cancer Lett; 1996 Jul; 104(2):225-31. PubMed ID: 8665492
[TBL] [Abstract][Full Text] [Related]
19. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.
Gaidano G; Ballerini P; Gong JZ; Inghirami G; Neri A; Newcomb EW; Magrath IT; Knowles DM; Dalla-Favera R
Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5413-7. PubMed ID: 2052620
[TBL] [Abstract][Full Text] [Related]
20. Frequent mutations in the p53 gene in human myeloid leukemia cell lines.
Sugimoto K; Toyoshima H; Sakai R; Miyagawa K; Hagiwara K; Ishikawa F; Takaku F; Yazaki Y; Hirai H
Blood; 1992 May; 79(9):2378-83. PubMed ID: 1571549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
